NIH Grants $7.8M to Support Launch of Rare Disease Network for Myasthenia Gravis
The National Institutes of Health (NIH) awarded $7.8 million to researchers at George Washington University to launch a…
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The National Institutes of Health (NIH) awarded $7.8 million to researchers at George Washington University to launch a…
DAS Therapeutics has acquired GTP-004, an investigational oral treatment for myasthenia gravis, from GT Biopharma, the companies announced. GTP-004 will…
Patients with mild myasthenia gravis (MG) but with poorer nerve cell response in initial diagnostic tests are more likely…
Camurus AB and Ra Pharmaceuticals have signed an agreement to develop and manufacture a long-acting injectable formulation of…
Myasthenia gravis and multiple sclerosis (MS) may share immunological features, according to researchers who studied the rare case…
Almost 90% of patients diagnosed with myasthenia gravis develop other diseases, or comorbidities, while about 70% have treatment-related complications, a…
Myasthenia gravis and amyotrophic lateral sclerosis (ALS) may share common underlying cellular mechanisms mediated by anti-LRP4 antibodies, a rare…
Hormones produced by adipose (fat) tissue, called adipokines, can help assess the progression and status of myasthenia gravis, researchers…
Argenx is one step closer to launching a global Phase 3 trial to evaluate the potential of its therapy…
Mutations in the genetic sequence of the IL4R gene can increase the risk of myasthenia gravis in the Chinese…
Get regular updates to your inbox.